Lineage, Inc. Common Stock (LINE)vsReal Brokerage Inc (REAX)
LINE
Lineage, Inc. Common Stock
$35.99
-1.64%
REAL ESTATE · Cap: $8.93B
REAX
Real Brokerage Inc
$2.15
-3.15%
REAL ESTATE · Cap: $431.27M
Smart Verdict
WallStSmart Research — data-driven comparison
Lineage, Inc. Common Stock generates 172% more annual revenue ($5.36B vs $1.97B). REAX leads profitability with a -0.4% profit margin vs -1.9%. LINE earns a higher WallStSmart Score of 36/100 (F).
LINE
Hold36
out of 100
Grade: F
REAX
Hold35
out of 100
Grade: F
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+75.9%
Fair Value
$161.49
Current Price
$35.99
$125.50 discount
Intrinsic value data unavailable for REAX.
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Reasonable price relative to book value
Revenue surging 44.1% year-over-year
Safe zone — low bankruptcy risk
Areas to Watch
0.0% earnings growth
ROE of -1.2% — below average capital efficiency
Revenue declined 0.2%
Distress zone — elevated risk
Trading at 8.6x book value
0.0% earnings growth
Smaller company, higher risk/reward
Weak financial health signals
Comparative Analysis Report
WallStSmart ResearchBull Case : LINE
The strongest argument for LINE centers on Price/Book.
Bull Case : REAX
The strongest argument for REAX centers on Revenue Growth, Altman Z-Score. Revenue growth of 44.1% demonstrates continued momentum.
Bear Case : LINE
The primary concerns for LINE are EPS Growth, Return on Equity, Revenue Growth.
Bear Case : REAX
The primary concerns for REAX are Price/Book, EPS Growth, Market Cap.
Key Dynamics to Monitor
LINE profiles as a turnaround stock while REAX is a hypergrowth play — different risk/reward profiles.
REAX is growing revenue faster at 44.1% — sustainability is the question.
LINE generates stronger free cash flow (78M), providing more financial flexibility.
Monitor REIT - INDUSTRIAL industry trends, competitive dynamics, and regulatory changes.
Bottom Line
LINE scores higher overall (36/100 vs 35/100). Both earn "Hold" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Lineage, Inc. Common Stock
REAL ESTATE · REIT - INDUSTRIAL · USA
Lineage, Inc. (Ticker: LINE) is a pioneering biotechnology firm focused on regenerative medicine, specifically developing cutting-edge cell therapy solutions for treating debilitating conditions, including ocular diseases, spinal cord injuries, and various cancers. With its proprietary technologies and robust network of strategic collaborations, Lineage is poised to transform patient care through innovative therapeutic interventions. The company's commitment to advancing its diverse product pipeline and expediting clinical research positions it as an attractive investment opportunity for institutional investors seeking to engage in the forefront of healthcare advancements.
Visit Website →Real Brokerage Inc
REAL ESTATE · REAL ESTATE SERVICES · USA
Real Brokerage Inc. is a technology-driven residential real estate brokerage company. The company is headquartered in Toronto, Canada.
Visit Website →Compare with Other REIT - INDUSTRIAL Stocks
Want to dig deeper into these stocks?